The pharmaceutical drug discovery and development lifecycle averages in excess of 10 years, and over $1 billion dollars to bring a drug to market. Assessment of physiochemical and pharmacological properties is now conducted at very early stages of drug discovery for the purpose of accelerating the conversion of hits and leads into qualified development candidates.
Laser Diode Thermal Desorption (LDTD) is a “next generation” technology which features liquid samples deposited directly onto the LazWell plate, with throughput speeds routinely under 9 seconds per sample, and even faster using acoustic dispersion technology. Application notes and posters, articles and presentations concentrate on CYP Inhibition, HT-ADME and PK as well as High-Throughput Screening (HTS) support.
KEYWORDS:
KEYWORDS: